Weight Loss Drugs shake up investor and consumer preferences
Worries that weight loss drugs could slim down consumer staple sales have sent shares down in recent weeks. Some company bosses are even backing this idea: Walmart (US: WMT) chief executive John Furner didn’t help matters when he told Bloomberg that customers taking appetite-suppressing medications such as Wegovy and Mounjaro were buying fewer food items in stores. Shares in Coca-Cola (US:KO) and PepsiCo (US:PEP) have […]